Revenue - Cosmo Pharmaceuticals NV (SIX:COPN) - Alpha Spread

Watchlist Manager

Watchlist

Price: 71.6 CHF 1.13%

Updated:

Cosmo Pharmaceuticals NV
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Cosmo Pharmaceuticals NV
Revenue Peer Comparison

PRGO

JAZZ

AVDL

G

GHRS

OVB

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Cosmo Pharmaceuticals NV SIX:COPN	Revenue €96.7m	CAGR 3-Years 17%	CAGR 5-Years 8%	CAGR 10-Years 6%
	Perrigo Company PLC NYSE:PRGO	Revenue $4.6B	CAGR 3-Years 4%	CAGR 5-Years -1%	CAGR 10-Years 2%
	Jazz Pharmaceuticals PLC NASDAQ:JAZZ	Revenue $3.8B	CAGR 3-Years 16%	CAGR 5-Years 14%	CAGR 10-Years 15%
	Avadel Pharmaceuticals PLC NASDAQ:AVDL	Revenue $55.1m	CAGR 3-Years 76%	CAGR 5-Years -9%	CAGR 10-Years 31%
G	GH Research PLC NASDAQ:GHRS	Revenue $0	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Ovoca Bio PLC LSE:OVB	Revenue €0	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Cosmo Pharmaceuticals NV's Revenue amounts to 96.7m EUR.

Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Cosmo Pharmaceuticals NV have been 17% over the past three years , 8% over the past five years , and 6% over the past ten years .

Join more than 143,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.